MA52796A - Compositions et procédés de détection d'une lésion cérébrale traumatique - Google Patents
Compositions et procédés de détection d'une lésion cérébrale traumatiqueInfo
- Publication number
- MA52796A MA52796A MA052796A MA52796A MA52796A MA 52796 A MA52796 A MA 52796A MA 052796 A MA052796 A MA 052796A MA 52796 A MA52796 A MA 52796A MA 52796 A MA52796 A MA 52796A
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- detection
- methods
- brain injury
- traumatic brain
- Prior art date
Links
- 208000030886 Traumatic Brain injury Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000009529 traumatic brain injury Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/12—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Eye Examination Apparatus (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862678900P | 2018-05-31 | 2018-05-31 | |
US201862733025P | 2018-09-18 | 2018-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52796A true MA52796A (fr) | 2021-04-14 |
Family
ID=68697319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052796A MA52796A (fr) | 2018-05-31 | 2019-05-31 | Compositions et procédés de détection d'une lésion cérébrale traumatique |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210369873A1 (fr) |
EP (1) | EP3803416A4 (fr) |
JP (2) | JP7381500B2 (fr) |
CN (1) | CN112424606A (fr) |
AU (1) | AU2019279001A1 (fr) |
CA (1) | CA3100700A1 (fr) |
MA (1) | MA52796A (fr) |
WO (1) | WO2019232422A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3118325A1 (fr) | 2018-11-02 | 2020-05-07 | Amydis, Inc. | Composes de phosphate pour detecter des troubles neurologiques |
CA3154481A1 (fr) * | 2019-09-18 | 2021-03-25 | Amydis, Inc. | Methodes de detection de troubles neurologiques par liaison a une proteine tau phosphorylee |
CN117916225A (zh) * | 2021-07-15 | 2024-04-19 | 阿米达斯公司 | N-杂环基取代的2-氰基-3-(萘-2-基)丙烯酰胺衍生物作为荧光团用于检测类淀粉蛋白和类淀粉样蛋白以诊断神经退行性病症 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10047237A1 (de) * | 2000-09-23 | 2002-04-11 | Physoptics Opto Electronic Gmb | System zur Aufnahme des Netzhautreflexbildes |
US20060167057A1 (en) * | 2004-11-16 | 2006-07-27 | Xianqi Kong | Compounds for the treatment of CNS and amyloid associated diseases |
US9839699B2 (en) * | 2008-09-18 | 2017-12-12 | Yeda Research And Development Co., Ltd. | Optical method for detecting Alzheimer's disease by systemic administration of curcumin |
WO2011056958A2 (fr) * | 2009-11-06 | 2011-05-12 | Adlyfe, Inc. | Détection et traitement d'une lésion cérébrale traumatique |
ES2546063T3 (es) * | 2009-12-10 | 2015-09-18 | The Regents Of The University Of California | Agentes de enlace a amiloides |
JP5863797B2 (ja) * | 2010-08-16 | 2016-02-17 | コグノプティックス, インコーポレイテッド | アミロイドタンパク質を検出するためのデバイス |
CN103228200A (zh) * | 2010-10-25 | 2013-07-31 | 史提芬·维杜纳 | 阿兹海默症、脑部创伤、黄斑变性与复数神经退化失调及眼病的诊断、预防以及预后侦测视网膜中淀粉样蛋白的装置与方法 |
US9588129B2 (en) * | 2013-03-15 | 2017-03-07 | Amira Medical Technologies Inc. | Methods for analyzing blood to detect diseases associated with abnormal protein aggregation |
WO2015070234A2 (fr) * | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Composés neuroprotecteurs et leur utilisation |
ES2946754T3 (es) * | 2014-03-19 | 2023-07-25 | Amydis Diagnostics Inc | Agentes para detección de amiloides y métodos para utilizar los mismos |
US9605315B2 (en) * | 2014-03-26 | 2017-03-28 | The University Of Montana | Detection of traumatic brain injury |
WO2015188142A1 (fr) * | 2014-06-05 | 2015-12-10 | Cedars-Sinai Medical Center | Diagnostic et surveillance d'une lésion cérébrale traumatique par imagerie des anomalies rétiniennes |
AU2015330355B2 (en) * | 2014-10-06 | 2021-09-23 | Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca | Markers and their use in brain injury |
WO2017004560A1 (fr) * | 2015-07-02 | 2017-01-05 | The Regents Of The University Of California | Procédés et compositions pour des agrégats amyloïdes |
GB201603967D0 (en) * | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
CA3118325A1 (fr) * | 2018-11-02 | 2020-05-07 | Amydis, Inc. | Composes de phosphate pour detecter des troubles neurologiques |
-
2019
- 2019-05-31 EP EP19810892.0A patent/EP3803416A4/fr active Pending
- 2019-05-31 JP JP2020567093A patent/JP7381500B2/ja active Active
- 2019-05-31 CA CA3100700A patent/CA3100700A1/fr active Pending
- 2019-05-31 US US16/973,028 patent/US20210369873A1/en active Pending
- 2019-05-31 CN CN201980044404.1A patent/CN112424606A/zh active Pending
- 2019-05-31 AU AU2019279001A patent/AU2019279001A1/en active Pending
- 2019-05-31 MA MA052796A patent/MA52796A/fr unknown
- 2019-05-31 WO PCT/US2019/034977 patent/WO2019232422A1/fr unknown
-
2023
- 2023-11-02 JP JP2023188467A patent/JP2024028695A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN112424606A (zh) | 2021-02-26 |
EP3803416A4 (fr) | 2022-05-18 |
JP7381500B2 (ja) | 2023-11-15 |
EP3803416A1 (fr) | 2021-04-14 |
JP2024028695A (ja) | 2024-03-05 |
WO2019232422A1 (fr) | 2019-12-05 |
CA3100700A1 (fr) | 2019-12-05 |
US20210369873A1 (en) | 2021-12-02 |
AU2019279001A1 (en) | 2020-12-03 |
JP2021525875A (ja) | 2021-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA43822A (fr) | Compositions et procédés de synthèse de phosphoramidite et d'oligonucléotides | |
MA46427A (fr) | Compositions d'oligonucléotides et procédés associés | |
MA52494A (fr) | Formes solides d'un inhibiteur de fgfr et leurs procédés de préparation | |
MA44990A (fr) | Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-l1 | |
MA51103A (fr) | Compositions et procédés de traitement de l'atrophie musculaire et de la dystrophie myotonique | |
MA45688A (fr) | Compositions et procédés de potentialisation d'agents antimicrobiens | |
MA42043A (fr) | Anticorps anti-ox40 et procédés d'utilisation de ceux-ci | |
MA50636A (fr) | Compositions et procédés pour inhiber l'activité d'arginase | |
MA45270A (fr) | Compositions d'oligonucléotides et procédés associés | |
MA42269A (fr) | Compositions et procédés d'inhibition de l'activité de l'arginase | |
MA51796A (fr) | Procédés et compositions pour l'administration de protéines thérapeutiques | |
MA45798A (fr) | Compositions et procédés d'inhibition de masp-3 pour le traitement de maladies et troubles divers | |
MA49045A (fr) | Compositions et procédés destinés à la distribution régulée d'acide | |
MA44991A (fr) | Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-1 | |
MA48779A (fr) | Formes cristallines d'inhibiteur de fgfr et leurs procédés de préparation | |
MA44740A (fr) | Variantes de capsides de virus adéno-associé et leurs procédés d'utilisation | |
MA53239A (fr) | Procédés d'administration de certains inhibiteurs de vmat2 | |
MA49069A (fr) | Procédés et compositions pour le traitement d'apnée du sommeil | |
MA52134A (fr) | Compositions et procédés pour l'édition génomique | |
MA52796A (fr) | Compositions et procédés de détection d'une lésion cérébrale traumatique | |
MA50045A (fr) | Composés spirocycliques et procédés de préparation et d'utilisation de ceux-ci | |
MA53445A (fr) | Procédés et compositions pour la modification de plantes | |
MA50849A (fr) | Substances et procédés pour le traitement d'hémoglobinopathies | |
MA44234A (fr) | Procédés de traitement ou de prévention de l'athérosclérose par administration d'un inhibiteur d'angptl3 | |
MA55893A (fr) | Procédés d'administration de certains inhibiteurs de vmat2 |